Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy.
暂无分享,去创建一个
M. Sabatine | E. Braunwald | C. Cannon | Jacqueline Buros | C. Gibson | V. Kunadian | Yuri B. Pride | Lauren N. Ciaglo | Matthew C. Southard | Caitlin J. Harrigan
[1] E. Braunwald,et al. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial. , 2006, Journal of the American College of Cardiology.
[2] A. Skene,et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.
[3] M. Sabatine,et al. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial. , 2005, American heart journal.
[4] E. Antman,et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. , 2003, Journal of the American College of Cardiology.
[5] F. Burzotta,et al. Stenting of Culprit Lesions in Unstable Angina Leads to a Marked Reduction in Plaque Burden: A Major Role of Plaque Embolization?: A Serial Intravascular Ultrasound Study , 2003, Circulation.
[6] E. Braunwald,et al. Relationship of the TIMI Myocardial Perfusion Grades, Flow Grades, Frame Count, and Percutaneous Coronary Intervention to Long-Term Outcomes After Thrombolytic Administration in Acute Myocardial Infarction , 2002, Circulation.
[7] R. Erbel,et al. Reduced coronary and inotropic reserves with coronary microembolization. , 2002, American journal of physiology. Heart and circulatory physiology.
[8] E. Antman,et al. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience). , 2001, The American journal of cardiology.
[9] R. Erbel,et al. Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. , 2000, American journal of physiology. Heart and circulatory physiology.
[10] C M Gibson,et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.
[11] S. Greenhouse,et al. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial , 1999 .
[12] I. Meredith,et al. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. , 1999, Circulation.
[13] R. Erbel,et al. Coronary Microembolization—Its Role in acute coronary syndromes and interventions , 1999, Herz.
[14] E. Braunwald,et al. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. , 1999, Circulation.
[15] D. Holmes,et al. Rescue angioplasty after failed thrombolysis: technical and clinical outcomes in a large thrombolysis trial. GUSTO-1 Angiographic Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. , 1998, Journal of the American College of Cardiology.
[16] E. Braunwald,et al. TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.
[17] J. Rowley,et al. Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death. , 1995, European heart journal.
[18] E. Topol,et al. Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction. , 1994, Circulation.
[19] Gusto Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. , 1993, The New England journal of medicine.
[20] U. Tebbe,et al. Impact of early perfusion status of the infarct-related artery on short-term mortality after thrombolysis for acute myocardial infarction: retrospective analysis of four German multicenter studies. , 1993, Journal of the American College of Cardiology.
[21] F. Belloni,et al. Role of nitric oxide in hypoxic coronary vasodilatation in isolated perfused guinea pig heart. , 1993, The American journal of physiology.
[22] H. Hellstrom. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. , 1991, Circulation.
[23] K. Lance Gould,et al. Coronary Artery Stenosis , 1990 .
[24] R. Califf,et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. , 1990, Circulation.
[25] R. Berne,et al. The cardiac effects of adenosine. , 1989, Progress in cardiovascular diseases.
[26] M. Hori,et al. Role of adenosine in hyperemic response of coronary blood flow in microembolization. , 1986, The American journal of physiology.
[27] W. Ganz,et al. The thrombolysis in myocardial infarction (TIMI) trial. , 1985, The New England journal of medicine.
[28] H. Rowsell,et al. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. , 1967, Laboratory investigation; a journal of technical methods and pathology.
[29] D. Ardissino,et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. , 2005, European heart journal.
[30] H. S. Mueller,et al. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. , 1985, The New England journal of medicine.
[31] R. Berne,et al. Coronary occlusion and embolization: effect on blood flow in adjacent arteries. , 1966, The American journal of physiology.